These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11034071)

  • 41. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
    Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
    Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
    Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
    Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
    Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
    Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.
    Huang SL; Wu Y; Yu H; Zhang P; Zhang XQ; Ying L; Zhao HF
    Acta Pharmacol Sin; 2006 Feb; 27(2):242-8. PubMed ID: 16412276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection.
    Yao X; Yoshioka Y; Eto Y; Morishige T; Okada Y; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2007 Oct; 362(2):419-24. PubMed ID: 17707336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues.
    Ritz JM; Kühle O; Riethdorf S; Sipos B; Deppert W; Englert C; Günes C
    Cancer Res; 2005 Feb; 65(4):1187-96. PubMed ID: 15735002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.
    Kagawa S; Pearson SA; Ji L; Xu K; McDonnell TJ; Swisher SG; Roth JA; Fang B
    Gene Ther; 2000 Jan; 7(1):75-9. PubMed ID: 10680019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
    Yin J; Fu P; Wang X; Jin G; Xiu R
    J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Toyota H; Kondo S; Kyo S; Mizuguchi J
    Anticancer Res; 2006; 26(1A):99-105. PubMed ID: 16475685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of osm gene driven by hTERT gene promoter inhibits cancer cells proliferation in vitro].
    Yang YJ; Zheng XF; Zhu J; Lu X; Luo Y; Sun ZX
    Ai Zheng; 2003 Jun; 22(6):575-8. PubMed ID: 12948403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
    Oh S; Song YH; Kim UJ; Yim J; Kim TK
    Biochem Biophys Res Commun; 1999 Sep; 263(2):361-5. PubMed ID: 10491298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
    Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
    Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells.
    Si SY; Song SJ; Zhang JZ; Liu JL; Liang S; Feng K; Zhao G; Tan XQ
    Oncol Rep; 2011 Aug; 26(2):377-82. PubMed ID: 21567104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.